In short, the results of this study revealed LINC01134, a novel negative regulator of ferroptosis, up-regulates GPX4 expression by enhancing the recruitment of the transcription factor Nrf2 to the GPX4 promoter, thereby increasing liver cancer resistance to OXA. Here, LINC01134 is linked to liver cancer.